The Boland Lab at Massachusetts General Hospital focuses on blood-based techniques for assessing changes in the tumor microenvironment through analysis of circulating exosomes.
Research & Clinical Trials
Research topics in the Cusack Laboratory include molecular targeted therapies for colorectal cancer, melanoma, Merkel cell cancer and carcinomatosis, and improving delivery of surgical cancer care in resource-limited settings.
The research mission of the Head and Neck Translational Immuno-Oncology Research Lab at Massachusetts General Hospital is to rapidly translate innovative, biomarker-driven immunotherapies that have the potential to improve treatment outcomes for patients with head and neck cancer.
The Hughes Lab developed a cancer risk assessment software (Hughes riskApps™) that focuses on increasing the quality and efficiency of care while decreasing cost.
The Laboratory of Gastrointestinal Epithelial Biology works to unravel the molecular mechanisms that underline the processes of growth and differentiation within intestinal epithelia, focusing on gut mucosal defense and how the host interacts with the intestinal microbiota.
The Liss Laboratory in the Division of Gastrointestinal and Oncologic Surgery at Massachusetts General Hospital is interested in understanding the molecular mechanisms that contribute to pancreatic cancer.
The Lubitz Lab focuses on improving the quality of care for patients with thyroid, parathyroid and adrenal disorders.
Research topics in the Maheswaran Lab include tumorigenesis, breast cancer and cancer genetics.
The Oncolytic Virus Laboratory at Massachusetts General Hospital seeks to understand how oncolytic viruses, a new class of tumor immunotherapy or cancer treatment, mediate antitumor activity.
The focus of the basic and translational laboratory efforts is the molecular mechanisms underlying the initiation, progression, and maintenance of pancreatic disease and cancer, specifically the contribution of developmental genes.